|
|
|
|
Click
Here For Low Prices On Vaniqa Vaniqa is an enzyme inhibitor used topically to slow the growth of unwanted facial hair in women. Vaniqa (eflornithine hydrochloride) Cream, 13.9% demonstrated in clinical trials that it is effective in slowing the growth of unwanted facial hair in up to 60 percent of women. Vaniqa takes up to 2 months to work.
Vaniqa will not replace current hair removal methods such as tweezing, waxing or shaving. Instead it complements those methods by slowing hair growth. Vaniqa has a unique mechanism of action and is believed to work by blocking an enzyme that is necessary for hair growth. Follow the directions for using this Vaniqa provided by your doctor. Vaniqa comes with a patient information leaflet which should be read carefully. Apply a thin layer of Vaniqa to the affected areas of the face and under the chin, at least 5 minutes after hair removal (e.g., plucking, shaving). Rub in thoroughly. Do not wash the treated area for at least 4 hours. Wait at least 8 hours between applications of this medicine. Cosmetics or sunscreens may be applied after the medicine has dried. Side effects that may go away during treatment include stinging, burning, redness, tingling, rash of the skin or hair bumps (folliculitis). If a dose is missed, skip the missed dose and return to the regular dosing schedule. Do not apply 2 doses at once. Vaniqa is a prescription drug for external use only. On July 31, 2000, Bristol-Myers Squibb Company and The Gillette Company announced that the U.S. Food and Drug Administration (FDA) had approved Vaniqa (eflornithine hydrochloride) Cream, 13.9% as the first topical prescription treatment for women with unwanted facial hair.
Click
Here For Low Prices On Vaniqa For a safe alternative to Vaniqa, suitable for both men and women, click here Other Vaniqa Information pages: |
